Jazz Argues Drug Patent Should Stay In Orange Book
Jazz Pharmaceuticals tried to convince the Federal Circuit in oral arguments on Tuesday to overturn a lower court order to remove its patent for its narcolepsy drug from the Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article